Last Updated: May 1, 2026

Profile for Canada Patent: 3082522


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 3082522

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,064,438 Oct 9, 2039 Genentech Inc XOFLUZA baloxavir marboxil
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Patent CA3082522 Overview: Scope, Claims, and Landscape

Last updated: February 22, 2026

What is the Scope of Patent CA3082522?

Patent CA3082522 covers a novel pharmaceutical compound, specific formulations, or methods of use. It generally pertains to a specific chemical entity, its pharmacological application, or manufacturing process. The patent's geographical scope is limited to Canada, with potential international priority or family members filed elsewhere.

Key features of scope:

  • Claims: Define the legal boundary, specifying the protected compound, formulation, or method.
  • Priority date: Established by the filing date, determining novelty and inventive step status.
  • Duration: Standard patent term in Canada is 20 years from filing, subject to maintenance fees.

What Do the Claims of CA3082522 Cover?

The claims in CA3082522 are typically divided into independent and dependent types.

Types of Claims

Claim Type Description Examples
Independent Broad claims defining core invention Patent claims covering the chemical compound or key use method
Dependent Narrower claims refining elements of independent claims Claims specifying particular chemical substitutions, formulations, or dosages

Typical Claim Scope

  • Chemical structure: Patent likely claims a specific compound or class of compounds.
  • Method of use: Claims may specify treatment of particular diseases.
  • Formulation: Claims on pharmaceutical compositions containing the compound.
  • Manufacturing process: Claims on synthesis methods or production techniques.

Key Considerations

  • Claim breadth: Broad claims encompassing a wide chemical class increase exclusivity but may face validity challenges.
  • Novelty and inventive step: The claims must demonstrate significant differentiation from known prior art.
  • Possible limitations: Narrow claims protect specific embodiments, potentially limiting scope.

Patent Landscape in Canada

Competing Patents and Prior Art

  • International Patent Family: Similar patents filed in jurisdictions like the US (e.g., USXXXXXXX), Europe (EPXXXXXX), covering similar compounds or uses.
  • Other Canadian patents: CA patents related to similar therapeutic areas or compounds, possibly citing or challenging CA3082522.
  • Published applications: Pending applications might threaten or expand scope.

Patent Filing Trends

  • Recent filings: A surge in filings around the same time indicates strategic patent protection.
  • Patent expiry: Anticipated expiry based on priority date, typically 20 years post-filing unless extensions applied.

Patent Challenges and Litigation

  • Potential invalidation: Based on prior art or lack of inventive step, especially if the claims are broad.
  • Opposition proceedings: Not common in Canada but possible within 9 months of grant for patents of higher strategic importance.

International Landscape

  • Patent families: Filing in multiple jurisdictions increases market protection.
  • Patent collaborations: Partnerships between originator companies and local firms can influence enforcement strategies.

Summary of Patent CA3082522 Landmarks

Year Event Notes
Filing Original patent application filed Date not specified here
Grant Patent granted in Canada Date typically 3-5 years after filing
Expiry Expected expiry (without extensions) 20 years from filing date

Key Takeaways

  • The patent protects a specific chemical entity and its uses, with claims likely spanning compounds, formulations, and methods.
  • Claim scope varies from broad to narrow, balancing exclusivity against validity risks.
  • The Canadian patent landscape involves similar filings, potential challenges, and international patent strategies.
  • Enforcement depends on validity considerations and potential infringement actions against generics or biosimilars.

5 FAQs

  1. Can the claims of CA3082522 be challenged?
    Yes, through invalidation procedures based on prior art or obviousness arguments.

  2. Does the patent cover method of treatment?
    Likely, if the claims include therapeutic methods; check the exact language for specifics.

  3. Are there international patents related to CA3082522?
    Most likely, the applicant filed in other jurisdictions, creating a patent family.

  4. What is the typical patent term for this patent?
    20 years from the application filing date, subject to maintenance fees.

  5. How does the claims scope impact generic entry?
    Broader claims can delay generic entry; narrow claims might allow earlier entry if invalidated.


References

[1] Canadian Intellectual Property Office. (2023). Patent search and examination guidelines. Retrieved from https://www.ic.gc.ca/eic/site/cipointernet-internetopic.nsf/eng/h_wr00719.html

[2] World Intellectual Property Organization (WIPO). (2023). Patent landscape reports. Retrieved from https://www.wipo.int/patents/en/

[3] European Patent Office. (2023). Patent search tools. Retrieved from https://worldwide.espacenet.com/

[4] US Patent and Trademark Office. (2023). Patent examination guidelines. Retrieved from https://www.uspto.gov/patents/laws-and-regulations/exam-guidelines

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.